Tirzepatide represents a groundbreaking therapeutic agent for individuals struggling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://emilyygbk485912.articlesblogger.com/62930618/tirzepatide-a-game-changer-for-type-2-diabetes